Status:
TERMINATED
To Determine the Efficacy of a Laser Device for the Treatment of Hidradenitis Suppurativa
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
CoolTouch, Inc
Conditions:
Hidradenitis Suppurativa
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
A research study to determine the efficacy of a 1320 nm laser device for the treatment of hidradenitis suppurativa.
Detailed Description
Hidradenitis Suppurativa is a chronic, scarring disease. The treatments available for this condition are not very effective and work only for some patients. Recently, a 1320nm laser device has been a...
Eligibility Criteria
Inclusion
- Age equal to or greater than 18 years
- General good health and willingness to participate and ability to comply with the study protocol
- Biopsy proven hidradenitis suppurativa
Exclusion
- Age \< 18 years
- Pregnancy
- Hx of collagen vascular or photosensitive disorders
- Inability to follow-up with treatments
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2006
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00367328
Start Date
April 1 2005
End Date
April 1 2006
Last Update
April 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Davis Medical Center Department of Dermatology
Sacramento, California, United States, 95817